Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | AMPH | Deflin Gayle | Dir | A - Grant | $0.00 | +3,076 | 5,792 | +113% | $0 |
| D | 2024-06-05 | 2024-06-03 | AMPH | Deflin Gayle | Dir | A - Grant | $0.00 | +6,864 | 6,864 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | A | A | 3,076 | $0.00 | 5,792 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 3, 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-03 | A | A | 6,864 | $0.00 | 6,864 | D | $42.25 · — to 2034-06-03 | 6,864 Common Stock | (F2) All of the shares subject to the option vest on June 3, 2025. |